Untreated Advanced or Recurrent Thymic Carcinomas

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Untreated Advanced or Recurrent Thymic Carcinomas trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT05832827

First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Art…

A phase II, investigator-initiated, non-randomized, open-label, single-arm, multicenter study to evaluate the efficacy and safety of Carboplatin/Paclitaxel/Lenv…

Japan35 participantsStarted 2023-09-04

Treatment: MK-3475, Lenvatinib

All recent trials (2 shown)

CompletedPhase 1

NCT00020579

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

RATIONALE: MS-275 may stop the growth of cancer cells by blocking the enzymes necessary for their growth. PURPOSE: This phase I trial is studying the side effe…

United States75 participantsStarted 2001-03

Treatment: entinostat